Drug Use Investigation for ALLERMIST

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Rhinitis

Treatments: Drug: Fluticasone

Study type: Observational

Funder types: Industry

Identifiers

NCT01376206

113407

Details and patient eligibility

About

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

Enrollment: 2,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of allergic rhinitis
• Use ALLERMIST for the first time
• Expected to use ALLERMIST for long-term (1 year)

Exclusion criteria

• Subjects with infection which fluticasone is not effective
• Subjects with deep mycosis
• Subjects with hypersensitivity to fluticason

Trial design

2,000 participants in 1 patient group

Subjects prescribed ALLERMIST

Description:

Subjects with allergic rhinitis prescribed ALLERMIST during study period

Treatment:

Drug: Fluticasone